How Long Does Enzalutamide — Take to Work?

Possibly, yes. Some patients notice an improvement in pain or fatigue before their PSA begins to fall, while others see the PSA change first and feel better gradually over weeks. Neither pattern is more or less likely to mean the treatment is working — they reflect how different people's bodies respond. Report any change in symptoms to your team rather than trying to interpret it yourself, because symptoms are part of how they assess response.

You can notice things, but you cannot draw a conclusion from them without the blood tests and clinical picture. Reduced bone pain, improved energy and better sleep are things some patients report in the early weeks of responding. But absence of these does not mean the drug is not working — some people respond well on testing while noticing little change in daily life at first. Keep a brief note of how you feel each day and share it at each appointment.

Tell your oncologist straight away, but do not stop taking enzalutamide on your own. A rise in PSA in the first weeks does not always mean treatment failure. Your oncologist will look at the size of the rise, your symptoms and the broader picture before making any decision. The mistake to avoid is drawing a conclusion from one number without the context that surrounds it — that is what your team is trained to do.

Enzalutamide is taken continuously, not in cycles, for as long as it is keeping the cancer under control and you are tolerating it. There is no fixed course length the way there is with some chemotherapy regimens. Your oncologist will monitor response at regular intervals and continue the drug until either it stops being effective or side effects make it too difficult to continue. Some patients stay on it for years.

Yes. How quickly a response appears — and how deep that response is — varies between patients. Factors that influence this include how sensitive the cancer's androgen receptors are to the drug, whether the cancer has developed resistance from earlier treatment, and where in the body the disease is active. Your oncologist will take your individual situation into account when explaining what to expect, rather than giving you a one-size-fits-all timeline.

At the three-month review, your oncologist will compare your current PSA to your baseline reading and to any intermediate checks. They will ask about your symptoms — particularly pain, fatigue and urinary function — and assess your overall fitness. If imaging was part of your initial staging, they may review existing scans or arrange new ones. All of this feeds into one question: is the disease stable, responding, or progressing? The answer shapes the next phase of your plan.